Celebrex to add warnings, new use approved

08/2/2005 | MarketWatch

Pfizer said the arthritis drug's label would now carry a prominent warning about possible cardiovascular risks and also should not be used to treat pain linked to heart bypass surgery. In addition, the company announced the FDA has approved the drug to treat ankylosing spondylitis, a form of arthritis of the spine.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care